Ensuring medication adherence with direct oral anticoagulant drugs Lessons from adherence with vitamin K antagonists (VKAs)

被引:39
作者
Di Minno, Alessandro [1 ]
Spadarella, Gaia [2 ]
Tufano, Antonella [2 ]
Prisco, Domenico [3 ]
Di Minno, Giovanni [2 ]
机构
[1] Univ Naples Federico II, Dipartimento Farm, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, I-80131 Naples, Italy
[3] Univ Florence, Dipartimento Med Sperimentale & Clin, I-50134 Florence, Italy
关键词
Direct oral anticoagulants; Persistence; Communication/cooperation between; patients and doctors; Ex vivo laboratory tests; Patient's awareness; Every day practice; NONVALVULAR ATRIAL-FIBRILLATION; SECONDARY PREVENTION; PATIENT ADHERENCE; RISK-FACTORS; WARFARIN NONADHERENCE; AMBULATORY PATIENTS; IMPROVE ADHERENCE; ELDERLY-PATIENTS; THERAPY; PREDICTORS;
D O I
10.1016/j.thromres.2014.01.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Medication adherence (taking drugs properly) is uncommon among patients on warfarin. Poor adherence to warfarin leads to an increase in adverse medical events, including stroke in atrial fibrillation (AF). Factors related to patients, physicians and the health system account for poor adherence. Direct oral anticoagulants (DOACs) are easier to use than warfarin, with fewer drug and food interactions and no need for routine blood monitoring. A proper use of DOACs may reduce the risk of stroke in AF. However, in clinical settings where no laboratory monitoring is needed, a poor medication adherence is common and may impact clinical outcomes. In the management of chronic disorders, careful knowledge of the individual patient's attitudes and behaviors is a prerequisite for a successful doctor-patient communication. To increase patient's awareness of the risks and benefits of DOACs and, in turn, increase medication adherence, at each follow-up visit physicians should screen for priorities and motivational problems; check for the lack of understanding and/or knowledge; assess any health system or personal barriers to medication adherence; identify appropriate interventions and provide tailored support to patient needs. Dissemination of guidelines to the health care chain (prescribing physician, general practitioners, caregivers, nurses, pharmacists) further encourages medication adherence. However, the long-term effect of some of these strategies is unknown; one tool may not fit all patients, and the prescribing physician should consider individualization of these aids to ensure medication adherence and persistence (continuing to take drugs properly in long-term treatments) for DOACs in every day practice. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:699 / 704
页数:6
相关论文
共 50 条
  • [41] Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists
    Daher, Jessica
    Da Costa, Antoine
    Hilaire, Christophe
    Ferreira, Thomas
    Pierrard, Romain
    Guichard, Jean Baptiste
    Romeyer, Cecile
    Isaaz, Karl
    CLINICAL DRUG INVESTIGATION, 2020, 40 (04) : 343 - 353
  • [42] Comparison of Direct Oral Anticoagulants and Vitamin K Antagonists for Left Ventricular Thrombus: A Global Retrospective Study
    Yao, Zhihong
    Gue, Ying
    Lip, Gregory Y. H.
    AMERICAN JOURNAL OF MEDICINE, 2025, 138 (03) : 468 - 476
  • [43] Safety and Efficacy of Transcatheter Aortic Valve Replacement With Continuation of Vitamin K Antagonists or Direct Oral Anticoagulants
    Brinkert, Miriam
    Mangner, Norman
    Moriyama, Noriaki
    Keller, Lukas S.
    Hagemeyer, Daniel
    Crusius, Lisa
    Lehnick, Dirk
    Kobza, Richard
    Abdel-Wahab, Mohamed
    Laine, Mika
    Stortecky, Stefan
    Pilgrim, Thomas
    Nietlispach, Fabian
    Ruschitzka, Frank
    Thiele, Holger
    Linke, Axel
    Toggweiler, Stefan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (02) : 135 - 144
  • [44] The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients
    Kim, Daehoon
    Yang, Pil-Sung
    Jang, Eunsun
    Yu, Hee Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Kim, Jong-Youn
    Sung, Jung-Hoon
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Lip, Gregory Y. H.
    Joung, Boyoung
    EUROPACE, 2020, 22 (04): : 547 - 557
  • [45] Direct oral anticoagulants versus vitamin K antagonists for patients with left ventricular thrombus
    Xu, Zheng
    Li, Xiaomin
    Li, Xuewen
    Gao, Yuping
    Mi, Xiaolong
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (09) : 9427 - 9434
  • [46] When the Rubber Meets the Road: Adherence and Persistence with Non-Vitamin K Antagonist Oral Anticoagulants and Old Oral Anticoagulants in the Real World-A Problem or A Myth ?
    Suryanarayan, Deepa
    Schulman, Sam
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (08) : 852 - 859
  • [47] Response to: "Direct oral anticoagulants, vitamin K antagonists and simple single tooth extraction"
    Berton, Federico
    Stacchi, Claudio
    Costantinides, Fulvia
    Di Lenarda, Andrea
    Di Lenarda, Roberto
    CLINICAL ORAL INVESTIGATIONS, 2019, 23 (03) : 1497 - 1498
  • [48] Preference for direct oral anticoagulants in patients treated with vitamin K antagonists for venous thromboembolism
    Brekelmans, M. P. A.
    Kappelhof, M.
    Nieuwkerk, P. T.
    Nierman, M.
    Buller, H. R.
    Coppens, M.
    NETHERLANDS JOURNAL OF MEDICINE, 2017, 75 (02) : 50 - 55
  • [49] Lower-adherence direct oral anticoagulant use is associated with increased risk of thromboembolic events than warfarin
    Bawa, Danish
    Darden, Douglas
    Ahmed, Adnan
    Garg, Jalaj
    Karst, Edward
    Kabra, Rajesh
    Pothineni, Krishna
    Gopinathannair, Rakesh
    Mansour, Moussa
    Winterfield, Jeffrey
    Lakkireddy, Dhanunjaya
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2024, 67 (04) : 709 - 718
  • [50] Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands
    Hanemaaijer, Susan
    Sodihardjo, Fong
    Horikx, Annemieke
    Wensing, Michel
    De Smet, Peter A. G. M.
    Bouvy, Marcel L.
    Teichert, Martina
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (06) : 1128 - 1135